Similar articles for PMID: 31161860

Year	Number of Results
2005	1
2006	1
2007	2
2008	1
2009	1
2010	2
2011	5
2012	4
2013	5
2014	6
2015	6
2016	8
2017	14
2018	22
2019	16
2020	8
2021	6
2022	5
2023	3
2024	0

1

Manipulating the 5 Dimensions of the EuroQol Instrument: The Effects on Self-Reporting Actual Health and Valuing Hypothetical Health States.

Tsuchiya A, Bansback N, Hole AR, Mulhern B. Tsuchiya A, et al. Med Decis Making. 2019 May;39(4):379-392. doi: 10.1177/0272989X19851049. Epub 2019 Jun 4. Med Decis Making. 2019. PMID: 31161860

2

An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.

Feng Y, Herdman M, van Nooten F, Cleeland C, Parkin D, Ikeda S, Igarashi A, Devlin NJ. Feng Y, et al. Qual Life Res. 2017 Aug;26(8):2067-2078. doi: 10.1007/s11136-017-1541-5. Epub 2017 Mar 25. Qual Life Res. 2017. PMID: 28343350 Free PMC article.

3

Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study.

Ludwig K, von der Schulenburg JG, Greiner W. Ludwig K, et al. Health Qual Life Outcomes. 2017 Feb 20;15(1):39. doi: 10.1186/s12955-017-0617-9. Health Qual Life Outcomes. 2017. PMID: 28219389 Free PMC article.

4

Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?

Mulhern B, Shah K, Janssen MF, Longworth L, Ibbotson R. Mulhern B, et al. Value Health. 2016 Mar-Apr;19(2):210-7. doi: 10.1016/j.jval.2015.11.005. Epub 2016 Jan 8. Value Health. 2016. PMID: 27021755 Free article.

5

Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L.

Hobbins A, Barry L, Kelleher D, Shah K, Devlin N, Goni JMR, O'Neill C. Hobbins A, et al. Pharmacoeconomics. 2018 Nov;36(11):1345-1353. doi: 10.1007/s40273-018-0690-x. Pharmacoeconomics. 2018. PMID: 30051267 Free PMC article. Clinical Trial.

6

A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.

Ferreira PL, Antunes P, Ferreira LN, Pereira LN, Ramos-Goñi JM. Ferreira PL, et al. Qual Life Res. 2019 Dec;28(12):3163-3175. doi: 10.1007/s11136-019-02226-5. Epub 2019 Jun 14. Qual Life Res. 2019. PMID: 31201730

7

Understanding the composite dimensions of the EQ-5D: An experimental approach.

McDonald R, Mullett TL, Tsuchiya A. McDonald R, et al. Soc Sci Med. 2020 Nov;265:113323. doi: 10.1016/j.socscimed.2020.113323. Epub 2020 Aug 27. Soc Sci Med. 2020. PMID: 32919196 Free article. Clinical Trial.

8

Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.

Kreimeier S, Oppe M, Ramos-Goñi JM, Cole A, Devlin N, Herdman M, Mulhern B, Shah KK, Stolk E, Rivero-Arias O, Greiner W. Kreimeier S, et al. Value Health. 2018 Nov;21(11):1291-1298. doi: 10.1016/j.jval.2018.05.002. Epub 2018 Aug 8. Value Health. 2018. PMID: 30442276 Free article.

9

Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.

McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J. McCaffrey N, et al. Health Qual Life Outcomes. 2016 Sep 20;14(1):133. doi: 10.1186/s12955-016-0537-0. Health Qual Life Outcomes. 2016. PMID: 27644755 Free PMC article.

10

Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK.

Swinburn P, Lloyd A, Boye KS, Edson-Heredia E, Bowman L, Janssen B. Swinburn P, et al. Value Health. 2013 Dec;16(8):1156-62. doi: 10.1016/j.jval.2013.10.003. Epub 2013 Nov 11. Value Health. 2013. PMID: 24326169 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year